CAMP4 Therapeutics Corporation
CAMP · NASDAQ
12/31/2024 | 12/31/2023 | 11/30/2023 | 2/28/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$51,791 | -$49,291 | – | -$44,192 |
| Dep. & Amort. | $1,696 | $1,678 | – | $878 |
| Deferred Tax | $0 | $0 | – | $0 |
| Stock-Based Comp. | $4,032 | $2,907 | – | $1,377 |
| Change in WC | -$1,884 | -$154 | – | $373 |
| Other Non-Cash | $2,385 | $705 | – | $3,021 |
| Operating Cash Flow | -$45,562 | -$44,155 | – | -$38,543 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$441 | -$678 | – | -$4,025 |
| Net Acquisitions | $0 | $0 | – | $0 |
| Inv. Purchases | $0 | $0 | – | $0 |
| Inv. Sales/Matur. | $0 | $0 | – | $0 |
| Other Inv. Act. | $0 | $0 | – | $0 |
| Investing Cash Flow | -$441 | -$678 | – | -$4,025 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$824 | $116 | – | -$93 |
| Stock Issued | $0 | $0 | – | $0 |
| Stock Repurch. | $0 | $0 | – | $0 |
| Dividends Paid | $0 | $0 | – | $0 |
| Other Fin. Act. | $72,486 | $185 | – | $100,250 |
| Financing Cash Flow | $71,662 | $301 | – | $100,157 |
| Forex Effect | $0 | $0 | – | $25,601 |
| Net Chg. in Cash | $25,659 | -$44,532 | – | $83,190 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $40,004 | $84,536 | – | $26,947 |
| End Cash | $65,663 | $40,004 | – | $110,137 |
| Free Cash Flow | -$46,003 | -$44,833 | – | -$42,568 |